PECAM1 and chronic kidney disease: Zeisberg et al. have found that above 30% of fibroblasts in chronic kidney disease (CKD) mouse models might derive from endothelium, since they expressed CD31, being a well-known endothelial marker, aside from fibroblasts and myofibroblasts markers [81].